NEW YORK (GenomeWeb News) – Genetix today announced that it has acquired analysis and data management software firm SlidePath for undisclosed consideration.

Genetix said that the acquisition will complement its offerings in the digital pathology market. Specifically, the Hampshire, UK-based firm said that SlidePath's products will complement its Ariol platform, which is a digital imaging and analysis solution for quantifying biomarkers in tissue sections and tissue microarrays.

SlidePath will continue to operate from its headquarters in Dublin, Ireland.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.